Solid Biosciences Llc Stock Price on December 31, 2022
| SLDB Stock | USD 5.70 0.01 0.18% |
Below is the normalized historical share price chart for Solid Biosciences LLC extending back to January 26, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Solid Biosciences stands at 5.70, as last reported on the 29th of November, with the highest price reaching 5.78 and the lowest price hitting 5.59 during the day.
If you're considering investing in Solid Stock, it is important to understand the factors that can impact its price. Solid Biosciences LLC owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Solid Biosciences LLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Solid Biosciences' Risk Adjusted Performance of (0.09), coefficient of variation of (749.48), and Variance of 21.06 to confirm the risk estimate we provide.
At present, Solid Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 8.3 M, whereas Total Stockholder Equity is forecasted to decline to about 82.2 M. . At present, Solid Biosciences' Price To Sales Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.01, whereas Price Earnings Ratio is forecasted to decline to (1.34). Solid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of January 2018 | 200 Day MA 8.4078 | 50 Day MA 6.173 | Beta 1.928 |
Solid |
Sharpe Ratio = -0.1126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SLDB |
Estimated Market Risk
| 4.58 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Solid Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Solid Biosciences by adding Solid Biosciences to a well-diversified portfolio.
Price Book 1.3611 | Enterprise Value Ebitda (3.69) | Price Sales 3.6454 | Shares Float 19.2 M | Wall Street Target Price 17.4286 |
Related Headline
Mineralys Therapeutics, Headline on 9th of February 2023
Mineralys Therapeutics, exotic insider transaction detected by Akkaraju Srinivas
Filed transaction by Mineralys Therapeutics In director. Unconventional Insider trading
Solid Biosciences Valuation on December 31, 2022
It is possible to determine the worth of Solid Biosciences on a given historical date. On December 31, 2022 Solid was worth 5.76 at the beginning of the trading date compared to the closed value of 5.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Solid Biosciences stock. Still, in general, we apply an absolute valuation method to find Solid Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Solid Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Solid Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 5.30 | 5.81 | 5.28 | 5.81 | 17,645 | |
12/30/2022 | 5.76 | 5.76 | 5.30 | 5.38 | 38,830 |
| 5.36 | 5.65 | 5.36 | 5.62 | 23,203 |
| Backtest Solid Biosciences | | | Solid Biosciences History | | | Solid Biosciences Valuation | Previous | Next |
Solid Biosciences Trading Date Momentum on December 31, 2022
| On January 03 2023 Solid Biosciences LLC was traded for 5.62 at the closing time. The top price for the day was 5.65 and the lowest listed price was 5.36 . The trading volume for the day was 23.2 K. The trading history from January 3, 2023 was a factor to the next trading day price jump. The trading price change against the next closing price was 4.46% . The trading price change against the current closing price is 11.52% . |
Solid Biosciences LLC Fundamentals Correlations and Trends
By evaluating Solid Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Solid Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Solid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Solid Biosciences Stock history
Solid Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Solid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Solid Biosciences LLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Solid Biosciences stock prices may prove useful in developing a viable investing in Solid Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 19.9 M | 20.9 M | |
| Net Loss | -77.4 M | -81.3 M |
Solid Biosciences Quarterly Net Working Capital |
|
Solid Biosciences Stock Technical Analysis
Solid Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Solid Biosciences Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Solid Biosciences LLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Solid Biosciences November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Solid Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Solid Biosciences shares will generate the highest return on investment. By undertsting and applying Solid Biosciences stock market strength indicators, traders can identify Solid Biosciences LLC entry and exit signals to maximize returns
Solid Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Solid Biosciences' price direction in advance. Along with the technical and fundamental analysis of Solid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Solid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.31) | |||
| Treynor Ratio | (0.23) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |